Drug regulation reform--oversight : hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session.

FDA's drug approval process up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [sic] meets standards for safety and efficacy, March 1, 2005.
Published: (2005)

FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [sic] meets standards for safety and efficacy, March 1, 2005.
Published: (2005)

The Quayle Council's plans for changing FDA's drug approval process : a prescription for harm : twenty-sixth report
Published: (1992)

The Quayle Council's plans for changing FDA's drug approval process : a prescription for harm : twenty-sixth report
Published: (1992)

The adequacy of FDA to assure the safety of the nation's drug supply : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, February 13, March 22, 2007.
Published: (2007)

The adequacy of FDA to assure the safety of the nation's drug supply hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, February 13, March 22, 2007.
Published: (2007)

Competitive problems in the drug industry : drug testing : summary and analysis
Published: (1979)

The Food and Drug Administration's process for approving new drugs : oversight : hearings before the Subcommittee on Science, Research, and Technology of the Committee on Science and Technology, U.S. House of Representatives, Ninety-sixth Congress, first session, June 19, 21, July 11, 1979.
Published: (1979)

Legislative and administrative changes needed to improve regulation of drug industry : report to the Congress
Published: (1983)

The risks of prescription drugs
Published: (2010)

"Man-in-the-plant" revisited, a deceptive drug labeling practice continues : hearing before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Committee, House of Representatives, Ninety-sixth Congress, second session, March 6, 1980.
Published: (1980)

Preliminary report of the survey on drugs for rare disease
Published: (1982)

Preliminary report of the survey on drugs for rare disease
Published: (1982)

Drug shortages : FDA's ability to respond should be strengthened : testimony before the Committee on Health, Education, Labor, and Pensions, U.S. Senate
by: Crosse, Marcia
Published: (2011)

The Food and Drug Administration's process for approving new drugs : report
Published: (1980)

Perspectives of drug manufacturers : investigational new drug and new drug applications.
Published: (1990)

FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
Published: (1989)

FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
Published: (1989)

Regulation and drug development
by: Wardell, William M.
Published: (1975)

Regulation and drug development
by: Wardell, William M.
Published: (1975)

Perspectives of drug manufacturers : abbreviated new drug applications.
Published: (1990)

Las drogas baratas aprobadas por la FDA : los productos genéricos deben satisfacer altos niveles.
Published: (2004)

El proceso del desarrollo de las drogas y la FDA : cómo la agencia asegura que las drogas sean seguras y efectivas.
Published: (2002)

Drug shortages : FDA's ability to respond should be strengthened : report to congressional requesters.
Published: (2011)

Medicines for man ; the development, regulation, and use of prescription drugs
by: Dowling, Harry F. (Harry Filmore), 1904-2000
Published: (1970)

FDA review of drug applications
Published: (2013)

Drug safety : an update from the Food and Drug Administration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, March 10, 2010.
Published: (2013)

Drug safety : an update from the Food and Drug Administration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, March 10, 2010.
Published: (2012)

Drug compounding pharmacies risk and oversight issues
Published: (2013)

FDA's generic drug enforcement and approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, March 7 and June 5, 1991.
Published: (1992)

Drug discovery and development
Published: (1987)

To America's health a proposal to reform the Food and Drug Administration
by: Miller, Henry I.
Published: (2000)

To America's health : a proposal to reform the Food and Drug Administration
by: Miller, Henry I.
Published: (2000)

Drug discovery and design medical aspects
Published: (2002)

Drug Industry Antitrust Act : hearings before the United States House Committee on the Judiciary, Subcommittee on Antitrust, Eighty-Seventh Congress, second session, on May 17, 18, 23, 24, 1962.
Published: (1962)

Prescription drugs : the number, role, and ownership of pharmacy services administrative organizations : report to the Ranking Member, Committee on Energy and Commerce, House of Representatives.
Published: (2013)